Skip to main content
. 2014 Aug 7;110:94–103. doi: 10.1016/j.antiviral.2014.07.014

Fig. 2.

Fig. 2

Kaplan–Meier plot of time from first dose to alleviation of symptoms for subjects with confirmed influenza enrolled in a Phase 2b/3 clinical trial of nitazoxanide in subjects with uncomplicated influenza-like illness (Haffizulla et al., 2014, reprinted with permission from Elsevier).